Rice Hall James & Associates’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.31M Buy
1,552,628
+131,023
+9% +$442K 0.3% 80
2025
Q4
$4.02M Buy
1,421,605
+13,879
+1% +$71.6K 0.22% 105
2025
Q3
$9.8M Sell
1,407,726
-136,689
-9% -$964K 0.53% 56
2025
Q2
$9.14M Buy
1,544,415
+715,626
+86% +$4.12M 0.49% 53
2025
Q1
$5.3M Buy
828,789
+274,587
+50% +$2.65M 0.31% 72
2024
Q4
$6.58M Buy
554,202
+19,089
+4% +$325K 0.36% 67
2024
Q3
$14.8M Buy
535,113
+88,711
+20% +$2.22M 0.8% 34
2024
Q2
$10.6M Sell
446,402
-134,813
-23% -$3.16M 0.64% 46
2024
Q1
$10.2M Buy
581,215
+724
+0.1% +$10.7K 0.58% 50
2023
Q4
$9.16M Sell
580,491
-42,644
-7% -$440K 0.53% 50
2023
Q3
$5.36M Buy
623,135
+494,662
+385% +$3.51M 0.34% 74
2023
Q2
$1.01M Buy
+128,473
New +$894K 0.06% 215

Other funds holding ASPN

Rice Hall James & Associates's ASPN Position: Q1 2026 in Review

Rice Hall James & Associates increased its Aspen Aerogels (ASPN) stake by 9.2% in Q1 2026, buying an estimated $442K and bringing the position to 1,552,628 shares worth $5.31M. The position accounts for 0.3% of the portfolio, ranked #80.

Rice Hall James & Associates first reported a position in ASPN in Q2 2023 and has held it in 12 quarters since. The position peaked at $14.8M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Rice Hall James & Associates held 1,552,628 shares of Aspen Aerogels worth $5.31M as of Q1 2026.
  • Rice Hall James & Associates bought 131,023 Aspen Aerogels shares in Q1 2026, an estimated $442K.
  • Aspen Aerogels made up 0.3% of Rice Hall James & Associates's portfolio in Q1 2026, its #80 holding.
  • Rice Hall James & Associates first reported a position in Aspen Aerogels in Q2 2023 and has held it in 12 quarters since.
  • Rice Hall James & Associates's Aspen Aerogels position peaked at $14.8M in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.